Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells

Molecular Cancer Therapeutics

Volumn 3, Issue 3, 2004, Pages 327-334

  Biswas, Swarajit Kumar ^a,b   Huang, Jie ^a   Persaud, Shalini ^a,c   Basu, Alakananda ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CISPLATIN; ETOPOSIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROCASPASE 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SERINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DEPOLARIZATION; DOWN REGULATION; DRUG MECHANISM; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACETOPHENONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOPYRANS; BLOTTING, WESTERN; CARCINOMA, SMALL CELL; CASPASE 3; CASPASE 9; CASPASES; CELL DEATH; CELL LINE, TUMOR; CISPLATIN; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ENZYME INHIBITORS; ETOPOSIDE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MEMBRANE POTENTIALS; MITOCHONDRIA; PACLITAXEL; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 4444354570     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Saijo N. Combined modality therapy for small cell lung cancer. Oncology, 1992;49 Suppl 1:2-10.
2. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell, 1997;91:443-6.
3. Green DR, Reed JC. Mitochondria and apoptosis. Science, 1998;281: 1309-12.
4. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science, 1998;281:1322-6.
5. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y. Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res, 1994;54:6-8.
6. Jiang SX, Sato Y, Kuwao S, Kameya T. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol, 1995;177: 135-8.
7. Ohmori T, Podack ER, Nishio K, et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by Bcl-2. Biochem Biophys Res Commun, 1993;192:30-6.
8. Kaiser U, Schilli M, Haag U, et al. Expression of bcl-2-protein in small cell lung cancer. Lung Cancer, 1996;15:31-40.
9. Reed JC. Bcl-2 family proteins. Oncogene, 1996;17:3225-36.
10. Basu A, Akkaraju GR. Regulation of caspase activation and cisdiamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry, 1999;38:4245-51.
11. Vindelov LL, Christensen IbJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 1983;3:323-7.
12. Ito T, Deng X, Carr B, May WS. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem, 1997;272:11671-3.
13. Haldar S, Basu A, Croce CM. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res, 1998;58: 1609-15.
14. Basu A, Woolard MID, Johnson CL. Involvement of protein kinase C-δ in DNA damage-induced apoptosis. Cell Death & Differ, 2001;8: 899-908.
15. Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS, Poirier GG. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem, 1999; 274:28379-84.
16. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev, 2002;2:647-56.
17. Ziegler A, Luadke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U. Induction of apoptosis in small-cell lung cancer cells by antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J Natl Cancer Inst, 1997;89:1027-36.
18. Zangemeister-Wittke U, Schenker T, Luedke GH, Stahel RA. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxyrubicin, and cisplatin on small-cell lung cancer cell lines. Br J Cancer, 1998;78:1035-42.
19. Leech SH, Olie RA, Gautschi O, et al. Induction of apoptosis in lung-cancer cells following Bcl-xL anti-sense treatment. Int J Cancer, 2000; 86:570-6.
20. Kirsch DG, Doseff A, Chau N, et al. Caspase-3-dependent cleavage of bcl-2 promotes release of cytochrome C. J Biol Chem, 1999;274: 21155-61.
21. Del Bello B, Valentini MA, Zunino F, Comporti M, Maellaro E. Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cells. Oncogene, 2001;20:4591-5.
22. Schiavone N, Rosini P, Quattrone A, et al. A conserved AU-rich element in the 3′ untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J, 2000;14:174-84.
23. Basu A, Weixel K, Saijo N. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Cell Growth & Differ, 1996;7:1507-12.
24. Ruvolo PP, Deng X, Carr BK, May WS. A functional role for mitochondrial protein kinase Cα in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem, 1998;273:25436-42.
25. Yamomoto K, Ichijo H, Korsmeyer SJ. Bcl-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol, 1999;19:8469-78.
26. Wang S, Wang Z, Boise L, Dent P, Grant S. Loss of the Bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. Biochem Biophys Res Commun, 1999;259:67-72.
27. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J, 1997;16:968-77.
28. Waterhouse NJ, Goldstein JC, von Ahsen O, Schuler M, Newmeyer DD, Green DR. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol, 2001;153: 319-28.
29. Chu G. Cellular responses to cisplatin: the roles of DNA-binding proteins and DNA repair. J Biol Chem, 1994;269:787-90.
30. Kasahara K, Fujiwara Y, Nishio K, et al. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res, 1991;51:3237-42.
31. Zangemeister-Wittke U, Leech SH, Olie RA, et al. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcI-xL expression efficiently induces apoptosis in tumor cells. Clin Cancer Res, 2000;6: 2547-55.
32. Sartorius UA, Krammer PH. Upregulation of Bcl-2 in involved in mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer, 2002;97:584-92.